Citations

Showing 10 of 108094 citations.

Outcomes Following Direct Versus Indirect Decompression Techniques for Lumbar Spondylolisthesis
McKeithan, Lydia J. , Romano, Joseph , Waddell, William H. , Steinle, Anthony M. , Pennings, Jacquelyn S. , Nian, Hui , Archer, Kristin R. , Bydon, Mohamad , Knightly, John J. , Abtahi, Amir M. , Romano, Joseph W., Zuckerman, Scott L. , Stephens, Byron F.

Mayo Clinic

Spine | July 22, 2022 | Volume: 47 | Issue: 20 | Pages: 1443-1451

10.1097/brs.0000000000004396 | PMID 35867585 Get It

Study Design. Retrospective review. Objective. The aim was to compare outcomes at 3 and 12 months for patients with lumbar spondylolisthesis treated with direct decompression (DD) versus indirect decompression (ID) techniques. Summary of Background Data. Debate persists regarding the optimal surgical strategy to treat lumbar spondylolisthesis. Novel techniques relying on ID have shown superior radiographic outcomes compared to DD, however, doubt remains regarding their effectiveness in achieving adequate decompression. Currently, there is a paucity of data comparing the clinical efficacy of DD to ID. Methods. The Quality Outcomes Database (QOD), a national, multicenter prospective spine registry, was queried for patients who underwent DD and ID between April 2013 and January 2019. Propensity scores for each treatment were estimated using logistic regression dependent on baseline covariates potentially associated with outcomes. The propensity scores were used to exclude nonsimilar patients. Multivariable regression analysis was performed with the treatment and covariate as independent variables and outcomes as dependent variables. Results. A total of 4163 patients were included in the DD group and 86 in the ID group. The ID group had significantly lower odds of having a longer hospital stay and for achieving 30% improvement in back and leg pain at 3 months. These trends were not statistically significant at 12 months. There were no differences in ED5D scores or Oswestry disability index 30% improvement scores at 3 or 12 months. ID patient had a significantly higher rate of undergoing a repeat operation at 3 months (4.9% vs. 1.5%, P =0.015). Conclusion. Our study suggests that both DD and ID for the treatment of lumbar spondylolisthesis result in similar clinical outcomes, with the exception that those treated with ID experienced a lower reduction in back and leg pain at 3 months and a higher 3-month reoperation rate. This data can provide surgeons with additional information when counseling patients on the pros and cons of ID versus DD surgery.
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
Lu, Jessica Bo Li , Piper, Sarah , Zhao, Peishen , Wootten, Denise , Lu, Jessica , Piper, Sarah J , Miller, Laurence J. , Sexton, Patrick M.

Mayo Clinic

International Journal of Molecular Sciences | July 22, 2022 | Volume: 23 | Issue: 15 | Pages: 8069

10.3390/ijms23158069 | PMID 35897648 Get It

Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and Vasoactive Intestinal Peptide (VIP) are neuropeptides involved in a diverse array of physiological and pathological processes through activating the PACAP subfamily of class B1 G protein-coupled receptors (GPCRs): VIP receptor 1 (VPAC1R), VIP receptor 2 (VPAC2R), and PACAP type I receptor (PAC1R). VIP and PACAP share nearly 70% amino acid sequence identity, while their receptors PAC1R, VPAC1R, and VPAC2R share 60% homology in the transmembrane regions of the receptor. PACAP binds with high affinity to all three receptors, while VIP binds with high affinity to VPAC1R and VPAC2R, and has a thousand-fold lower affinity for PAC1R compared to PACAP. Due to the wide distribution of VIP and PACAP receptors in the body, potential therapeutic applications of drugs targeting these receptors, as well as expected undesired side effects, are numerous. Designing selective therapeutics targeting these receptors remains challenging due to their structural similarities. This review discusses recent discoveries on the molecular mechanisms involved in the selectivity and signaling of the PACAP subfamily of receptors, and future considerations for therapeutic targeting.
Cultivating Clinical Clarity through Computer Vision: A Current Perspective on Whole Slide Imaging and Artificial Intelligence
Patel, Ankush , Mohanty, Sambit K. , Sharma, Shivani , Gangal, Shivam, Eloy, Catarina , Patel, Ankush U, Eloy, Catarina , Patel, Ankush U , Shaker, Nada , Parwani, Anil Vasdev

Mayo Clinic

Diagnostics | July 22, 2022 | Volume: 12 | Issue: 8 | Pages: 1778

10.3390/diagnostics12081778 | PMID 35892487 Get It

Diagnostic devices, methodological approaches, and traditional constructs of clinical pathology practice, cultivated throughout centuries, have transformed radically in the wake of explosive technological growth and other, e.g., environmental, catalysts of change. Ushered into the fray of modern laboratory medicine are digital imaging devices and machine-learning (ML) software fashioned to mitigate challenges, e.g., practitioner shortage while preparing clinicians for emerging interconnectivity of environments and diagnostic information in the era of big data. As computer vision shapes new constructs for the modern world and intertwines with clinical medicine, cultivating clarity of our new terrain through examining the trajectory and current scope of computational pathology and its pertinence to clinical practice is vital. Through review of numerous studies, we find developmental efforts for ML migrating from research to standardized clinical frameworks while overcoming obstacles that have formerly curtailed adoption of these tools, e.g., generalizability, data availability, and user-friendly accessibility. Groundbreaking validatory efforts have facilitated the clinical deployment of ML tools demonstrating the capacity to effectively aid in distinguishing tumor subtype and grade, classify early vs. advanced cancer stages, and assist in quality control and primary diagnosis applications. Case studies have demonstrated the benefits of streamlined, digitized workflows for practitioners alleviated by decreased burdens.
Does MIS Play a Role in the Treatment of Advanced Ovarian Cancer?
Pereira, Augusto , Magrina, Javier F. , Magtibay, Paul M. , Neto, João Siufi , Siufi, Daniela, Pérez‐Medina, Tirso , Chang, Yu‐Hui H., Perez-Medina, Tirso , Pereira Sánchez, Augusto , Chang, Yu‐Hui

Mayo Clinic

Cancers | July 22, 2022 | Volume: 14 | Issue: 15 | Pages: 3579

10.3390/cancers14153579 | PMID 35892837 Get It

Neoadjuvant chemotherapy allows a minimally invasive approach for interval debulking in patients with ovarian cancer considered unresectable to no residual disease by laparotomy at diagnosis. The aim of the study was to evaluate the type of surgical approach at interval debulking (ID) after three courses of carboplatin and taxol in patients with unresectable ovarian cancer at diagnosis compared with the type of surgical approach at primary debulking (PD). A secondary objective was to compare the perioperative outcomes of MIS vs. laparotomy at ID. A retrospective review of the type of surgical approach at ID following three courses of carboplatin and taxol was compared with the surgical approach at PD, and a review of the perioperative outcomes of MIS vs. open at ID was performed during the period from 21 January 2012, through 21 February 2013, for stage IIIC > 2 cm or IV epithelial ovarian cancer (EOC) unresectable at diagnosis and the surgical approach at PD. During the study period, 127 patients with stage IIIC or IV EOC met the inclusion criteria. Minimally invasive surgery (MIS), laparoscopic or robotic, was used in 21.6% of patients at ID and in 23.3% of patients at PD. At ID, MIS patients had a shorter hospital stay as compared to laparotomy (2 vs. 8 days; p < 0.001). At 5 year follow-up, 31.5% of EOC patients were alive (ID MIS: 47.5% vs. ID open: 30%; PD MIS: 41% vs. PD open: 28%), while 24.4% had no evidence of disease (ID MIS: 39% vs. ID open: 19.5%; PD MIS: 32% vs. PD open: 22%). Among living patients, 22% had evidence of disease. Neoadjuvant chemotherapy is a form of chemo-debulking and allows a minimally invasive approach at interval debulking in about one-fifth of the patients, with initial disease deemed unresectable to no residual tumor at initial diagnosis.
Optimizing the First Response to Sepsis: An Electronic Health Record-Based Markov Decision Process Model
Rosenstrom, Erik , Meshkinfam, Sareh , Ivy, Julie S. , Goodarzi, Shadi Hassani, Capan, Müge , Huddleston, Jeanne M. , Romero‐Brufau, Santiago , Romero-Brufau, Santiago , Meshkinfam, Sareh

Mayo Clinic

Decision Analysis | July 22, 2022 | Volume: 19 | Issue: 4 | Pages: 265-296

10.1287/deca.2022.0455 Get It

Sepsis is considered a medical emergency where delays in initial treatment are associated with increased morbidity and mortality, yet there is no gold standard for identifying sepsis onset and thus treatment timing. We leverage electronic health record (EHR) data with clinical expertise to develop a continuous-time Markov decision process (MDP) optimal stopping model that identifies the optimal first intervention action (anti-infective, fluid, or wait). To study the impact of initial treatment of patients at risk for developing sepsis, we define the delayed treatment population who received delayed treatment upon admission or during hospitalization and serves as an approximation of the natural history of sepsis. We apply the optimal first treatment policy to sample patient visits from the nondelayed treatment population. This analysis indicates the average risk of death could be reduced by approximately 2.2%, the average time until treatment could be reduced by 106 minutes, and the average severity of the treatment state could be reduced by 15.5% compared with the treatment they received in the hospital. We study the properties of the optimal policy to define an easily interpretable initial treatment heuristic that considers a patient’s organ dysfunction, location, and septic shock status. This generalizable framework can inform personalized treatment of patients at risk for sepsis. History: This paper has been accepted for the Decision Analysis Special Issue on Emerging Topics in Health Decision Analysis. Funding: This material is based upon work supported by the National Science Foundation [Grant 1522107 (North Carolina State University), 1522106 (Mayo Clinic), and 1833538 (Drexel University)].
ASHP Statement on Telehealth Pharmacy Practice
Begnoche, Brendan R, Butler, Charlotte, Carson, Paige H, Darr, Andrea, Jenkins, Matthew T. , McDaniel, Robert B, Mourad, Hesham , Shipman, Colleen J., Stratton, Timothy P., Tran, Kelvin , Butler, C David, Jenkins, Matthew T, Le, Trinh , Tran, Kelvin, Wong, Kong (Kit)

Mayo Clinic

American Journal of Health-System Pharmacy | July 22, 2022 | Volume: 79 | Issue: 19 | Pages: 1728-1735

10.1093/ajhp/zxac188 | PMID 35866463 Get It

The AT(N) System for Describing Biological Changes in Alzheimer’s Disease: A Plain Language Summary
Hampel, Harald , Elhage, Aya, Blennow, Kaj , Gao, Peng , Vergallo, Andrea , Cummings, Jeffrey L. , Jack, Clifford R.

Mayo Clinic

Neurodegenerative Disease Management | July 22, 2022 | Volume: 12 | Issue: 5 | Pages: 231-239

10.2217/nmt-2022-0013 | PMID 35866745 Get It

Faculty Opinions recommendation of Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
Gersh, Bernard J.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742224642.793594283 Get It

Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort
Kent, David M. , Leung, Lester Y. , Puttock, Eric J. , Kallmes, David F. , Nelson, Jason , Vickery, Ellen M. , Chen, Wansu , Noyce, Alastair J , Kent, David M , Wang, Andy Yu-Der , Luetmer, Patrick H. , Fu, Sunyang , Zheng, Chengyi , Liu, Hongfang , Noyce, Alastair J.

Mayo Clinic

Annals of Neurology | July 22, 2022 | Volume: 92 | Issue: 4 | Pages: 620-630

10.1002/ana.26458 | PMID 35866711 Get It

Objective This study aimed to examine the relationship between covert cerebrovascular disease, comprised of covert brain infarction and white matter disease, discovered incidentally in routine care, and subsequent Parkinson disease. Methods Patients were ≥50 years and received neuroimaging for non‐stroke indications in the Kaiser Permanente Southern California system from 2009 to 2019. Natural language processing identified incidentally discovered covert brain infarction and white matter disease and classified white matter disease severity. The Parkinson disease outcome was defined as 2 ICD diagnosis codes. Results 230,062 patients were included (median follow‐up 3.72 years). A total of 1,941 Parkinson disease cases were identified (median time‐to‐event 2.35 years). Natural language processing identified covert cerebrovascular disease in 70,592 (30.7%) patients, 10,622 (4.6%) with covert brain infarction and 65,814 (28.6%) with white matter disease. After adjustment for known risk factors, white matter disease was associated with Parkinson disease (hazard ratio 1.67 [95%CI, 1.44, 1.93] for patients <70 years and 1.33 [1.18, 1.50] for those ≥70 years). Greater severity of white matter disease was associated with increased incidence of Parkinson disease(/1,000 person‐years), from 1.52 (1.43, 1.61) in patients without white matter disease to 4.90 (3.86, 6.13) in those with severe disease. Findings were robust when more specific definitions of Parkinson disease were used. Covert brain infarction was not associated with Parkinson disease (adjusted hazard ratio = 1.05 [0.88, 1.24]). Interpretation Incidentally discovered white matter disease was associated with subsequent Parkinson disease, an association strengthened with younger age and increased white matter disease severity. Incidentally discovered covert brain infarction did not appear to be associated with subsequent Parkinson disease. ANN NEUROL 2022;92:620–630
Applying Deep Learning to Establish a Total Hip Arthroplasty Radiography Registry
Rouzrokh, Pouria , Erickson, Bradley J. , Johnson, Quinn J. , Faghani, Shahriar , Vera-Garcia, Diana V. , Kremers, Hilal Maradit , Taunton, Michael J. , Wyles, Cody C. , Khosravi, Bardia , Erickson, Bradley J , Taunton, Michael J , Wyles, Cody C , Khosravi, Bardia , Maradit Kremers, Hilal , Rouzrokh, Pouria , Faghani, Shahriar , Vera-Garcia, Diana V

Mayo Clinic

Journal of Bone and Joint Surgery | July 22, 2022 | Volume: 104 | Issue: 18 | Pages: 1649-1658

10.2106/jbjs.21.01229 | PMID 35866648 Get It

Background: Establishing imaging registries for large patient cohorts is challenging because manual labeling is tedious and relying solely on DICOM (digital imaging and communications in medicine) metadata can result in errors. We endeavored to establish an automated hip and pelvic radiography registry of total hip arthroplasty (THA) patients by utilizing deep-learning pipelines. The aims of the study were (1) to utilize these automated pipelines to identify all pelvic and hip radiographs with appropriate annotation of laterality and presence or absence of implants, and (2) to automatically measure acetabular component inclination and version for THA images. Methods: We retrospectively retrieved 846,988 hip and pelvic radiography DICOM files from 20,378 patients who underwent primary or revision THA performed at our institution from 2000 to 2020. Metadata for the files were screened followed by extraction of imaging data. Two deep-learning algorithms (an EfficientNetB3 classifier and a YOLOv5 object detector) were developed to automatically determine the radiographic appearance of all files. Additional deep-learning algorithms were utilized to automatically measure the acetabular angles on anteroposterior pelvic and lateral hip radiographs. Algorithm performance was compared with that of human annotators on a random test sample of 5,000 radiographs. Results: Deep-learning algorithms enabled appropriate exclusion of 209,332 DICOM files (24.7%) as misclassified non-hip/pelvic radiographs or having corrupted pixel data. The final registry was automatically curated and annotated in <8 hours and included 168,551 anteroposterior pelvic, 176,890 anteroposterior hip, 174,637 lateral hip, and 117,578 oblique hip radiographs. The algorithms achieved 99.9% accuracy, 99.6% precision, 99.5% recall, and a 99.6% F1 score in determining the radiograph appearance. Conclusions: We developed a highly accurate series of deep-learning algorithms to rapidly curate and annotate THA patient radiographs. This efficient pipeline can be utilized by other institutions or registries to construct radiography databases for patient care, longitudinal surveillance, and large-scale research. The stepwise approach for establishing a radiography registry can further be utilized as a workflow guide for other anatomic areas. Level of Evidence: Diagnostic Level IV . See Instructions for Authors for a complete description of levels of evidence.